Cytokinetics (CYTK)
NASDAQ: CYTK
· Real-Time Price · USD
38.63
-0.09 (-0.23%)
At close: Aug 15, 2025, 3:59 PM
39.20
1.46%
After-hours: Aug 15, 2025, 07:57 PM EDT
Cytokinetics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 85.74M | 19.22M | 18.47M | 3.22M | 3.13M | 3.75M | 7.53M | 7.82M | 9.95M | 98.05M | 94.59M | 148.23M | 151.15M | 65.03M | 70.43M | 21.55M | 57.8M | 58.55M |
Cost of Revenue | 280.37M | 280.49M | 182.98M | 95.68M | 93.6M | 174.39M | 251.48M | 320.17M | 300.37M | 274.3M | 240.81M | 209.29M | 195M | 174.31M | 159.94M | 145.66M | 121.43M | 106.77M |
Gross Profit | -194.63M | -261.27M | -164.5M | -92.47M | -90.47M | -170.64M | -243.95M | -312.35M | -290.42M | -176.25M | -146.22M | -61.06M | -43.84M | -109.28M | -89.51M | -124.11M | -63.63M | -48.22M |
Operating Income | -546.98M | -565.64M | -536.25M | -524.63M | -506.09M | -497.97M | -496.2M | -495.82M | -481.99M | -370.82M | -324.2M | -218.88M | -179.64M | -223.56M | -186.31M | -201.02M | -126.63M | -104.19M |
Interest Income | 58.77M | 57.32M | 51.53M | 44.11M | 33.89M | 29.12M | 27.63M | 25.96M | 23.27M | 17.35M | 11.34M | 5.42M | 1.51M | 833K | 708K | 2.85M | 3.7M | 4.9M |
Pretax Income | -606.31M | -615.26M | -589.53M | -576.4M | -545.28M | -530.6M | -526.24M | -526.73M | -539.62M | -430.8M | -388.95M | -282.14M | -215.92M | -257.65M | -215.31M | -228.67M | -155.76M | -134.99M |
Net Income | -606.31M | -615.26M | -589.53M | -576.4M | -545.28M | -530.6M | -524.4M | -518.96M | -565.72M | -465.85M | -437.44M | -336.55M | -236.46M | -269.24M | -215.31M | -228.67M | -155.76M | -134.99M |
Selling & General & Admin | 242.08M | 227.18M | 215.31M | 197.09M | 180.55M | 169.45M | 173.61M | 183.47M | 191.58M | 194.57M | 177.98M | 157.81M | 135.79M | 114.28M | 96.8M | 76.91M | 63.01M | 55.97M |
Research & Development | 301.8M | 266.44M | 248.14M | 235.53M | 235.45M | 159.13M | 82M | 9.95M | 12.08M | 11.22M | 10.25M | 47.16M | 93.08M | 129.53M | 159.94M | 145.66M | 121.43M | 106.77M |
Other Expenses | -191.53M | -189.25M | -91.71M | -463K | -378K | 81.95M | 79.84M | 73.25M | 71.11M | -11.22M | 35.68M | 191.64M | 242.15M | 275.75M | 255.98M | 187.04M | 158.05M | 142.65M |
Operating Expenses | 352.35M | 304.37M | 371.74M | 432.16M | 415.62M | 327.33M | 252.25M | 183.47M | 191.58M | 194.57M | 177.98M | 157.81M | 135.79M | 114.28M | 96.8M | 76.91M | 63.01M | 55.97M |
Interest Expense | 92.1M | 92.14M | 86.51M | 80.98M | 72.68M | 61.75M | 57.67M | 56.87M | 58.64M | 55.09M | 51.16M | 43.75M | 35.1M | 32.24M | 29.71M | 30.51M | 32.83M | 35.69M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 632.72M | 584.86M | 554.72M | 527.85M | 509.22M | 501.72M | 503.74M | 503.63M | 491.94M | 468.87M | 418.79M | 367.11M | 330.79M | 288.59M | 256.74M | 222.57M | 184.43M | 162.74M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -1.85M | -7.77M | 26.1M | 35.05M | 48.48M | 54.4M | 20.3M | 11.54M | 246K | 246K | 477K | 290K |
Shares Outstanding (Basic) | 119.46M | 118.5M | 118.08M | 117.69M | 109.24M | 101.92M | 99.07M | 96.07M | 95.75M | 95.16M | 94.68M | 93.76M | 85.73M | 85M | 83.86M | 80.09M | 71.75M | 71.19M |
Shares Outstanding (Diluted) | 119.46M | 118.5M | 118.08M | 117.69M | 109.24M | 101.92M | 99.07M | 96.07M | 95.75M | 95.16M | 94.68M | 93.76M | 85.73M | 85M | 84.09M | 80.33M | 71.75M | 71.19M |
EPS (Basic) | -5.11 | -5.3 | -5.27 | -5.38 | -5.37 | -5.4 | -5.43 | -5.44 | -5.97 | -4.97 | -4.8 | -3.77 | -2.84 | -3.36 | -2.83 | -3.09 | -2.19 | -2.01 |
EPS (Diluted) | -5.11 | -5.3 | -5.27 | -5.38 | -5.37 | -5.4 | -5.43 | -5.44 | -5.97 | -4.97 | -4.8 | -3.77 | -2.84 | -3.36 | -2.83 | -3.09 | -2.19 | -2.01 |
EBITDA | -504.83M | -513.62M | -493.48M | -481.94M | -459.67M | -455.54M | -454.81M | -459.69M | -470.57M | -366.1M | -329.4M | -230.42M | -174.48M | -220.53M | -181.75M | -196.15M | -121.92M | -98.41M |
EBIT | -514.21M | -523.12M | -503.01M | -495.42M | -472.6M | -468.85M | -468.58M | -469.86M | -480.97M | -375.71M | -337.8M | -238.77M | -181.2M | -225.8M | -185.98M | -198.16M | -124.01M | -100.37M |
Depreciation & Amortization | 9.38M | 9.5M | 9.53M | 13.48M | 12.93M | 13.31M | 13.76M | 10.17M | 10.4M | 9.61M | 8.4M | 8.35M | 12.13M | 10.67M | 9.64M | 7.42M | 2.09M | 1.96M |